Cat Vaccine Market To Reach $2.5 Billion By 2030 | CAGR: 9.4%

Cat Vaccine Market Growth & Trends

The global cat vaccine market size is expected to reach USD 2.5 billion by 2030 and is anticipated to expand at a CAGR of 9.4% from 2024 to 2030, according to a new report by Grand View Research, Inc.Rising pet ownership, emerging diseases in cats, and rising disposable income is expected to increase the market value for cat vaccines. Furthermore, pharmaceutical industry investments are also expected to boost market growth.

The rising market trend is due to the growing awareness among pet owners about the necessity of cat vaccines, promoting preventive healthcare, and ensuring the well-being of their feline companions. Pet owners now prioritize products that match their pets' dietary needs and personal values, turning to online pet brands for convenient access to premium and nutritious pet items.

 Request a free sample copy or view report summary: Cat Vaccine Market Report

Cat Vaccine Market Report Highlights

• Based on vaccine type, the modified/attenuated live segment dominated the market with the largest revenue share of 50.1% in 2023. The demonstrated efficacy of modified/attenuated live vaccines against feline panleukopenia and herpesvirus, has boosted confidence in both pet owners and veterinarians.

• Based on disease type, the feline respiratory diseases (FRDs) segment held the largest share of 32.4% in 2023 owing to the increasing prevalence of FRDs, eventually driving market growth.

• The feline leukemia segment is anticipated to witness the fastest CAGR of 9.8% over the forecast period.

• Based on route of administration, the injectables segment held the largest market share, with 77.4% in 2023. Continuous research and development in vaccine technology are propelling the injectables segment in the market.

• Based on duration of immunity, the 1-year segment held the largest market share of 50.1% in 2023 and the diligent and evidence-based practices of veterinary organizations such as the American Association of Feline Practitioners (AAFP) guide the development of safe and effective vaccines.

• Based on component, the combined vaccine segment held the largest market share, with 64.0% in 2023, and is expected to grow at the fastest CAGR of 9.5% over the forecast period.

• In 2023, North America dominated the market with a revenue share of 38.1% owing to the strict regulations overseeing animal vaccines and upholding high-quality feline healthcare standards.

• Some of the major companies include Virbac; C.H. Boehringer Sohn AG & Co. KG.; Elanco; Zoetis; Merck & Co.; Bioveta, a.s.; Indian Immunologicals Ltd.; among others.

Cat Vaccine Market Segmentation

Grand View Research has segmented the global cat vaccine market based on vaccine type, disease type, route of administration, duration of immunity, component, and region:

Cat Vaccine Vaccine Type Outlook (Revenue, USD Million, 2018 - 2030)

• Modified/Attenuated Live

• Inactivated (Killed)

• Others

Cat Vaccine Disease Type Outlook (Revenue, USD Million, 2018 - 2030)

• Feline Leukemia

• Feline Panleukopenia (Feline Distemper)

• Feline Respiratory Diseases

• Feline Rabies

• Other Diseases

Cat Vaccine Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)

• Injectables

• Intranasal

• Oral

Cat Vaccine Duration of Immunity Outlook (Revenue, USD Million, 2018 - 2030)

• 1 Year

• 3 Year

• Others

Cat Vaccine Component Outlook (Revenue, USD Million, 2018 - 2030)

• Combined vaccines

• Mono vaccines

Cat Vaccine Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Thailand

  • Australia

  • South Korea

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East and Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Companies in the Cat Vaccine Market

• Virbac

• C.H. Boehringer Sohn AG & Co. KG.

• Elanco

• Zoetis

• Merck & Co.

• Bioveta, a.s.

• Indian Immunologicals Ltd.